Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SVRA · against 1,372 other Healthcare companies
Ranked #144 of 1,373 · scores higher than 90% of peers · safety percentile 90
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 80–89, including SVRA · Click a bar to see the companies
Mainly thanks to its current ratio and beta, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SVRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.21× | 0.24× | 52% | 33% | |
| BetaLower is better · 1,320 reported | 0.25 | 0.53 | 73% | 33% | |
| Current ratioHigher is better · 1,338 reported | 10.13× | 2.62× | 88% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 140 | 1.5B USD | 90 | 30 | |
| 141 | 4.0B CNY (≈$561M) | 90 | 33 | |
| 142 | 1.8B USD | 90 | 30 | |
| 143 | 1.1B USD | 90 | 50 | |
| 144 | 976M USD | 90 | 36 | |
| 145 | 6.5B CNY (≈$911M) | 90 | 62 | |
| 146 | 387M USD | 89 | 49 | |
| 147 | 255M USD | 89 | 38 | |
| 148 | 3.5B CNY (≈$491M) | 89 | 79 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score